Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.

scientific article published on December 2006

Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1677/ERC.1.01279
P698PubMed publication ID17259562
P5875ResearchGate publication ID6543736

P50authorJulia GeeQ42700685
Rajpal S BurmiQ79678737
P2093author name stringRobert I Nicholson
Helen E Jones
Richard A McClelland
Janice M Knowlden
Denise Barrow
Iain R Hutcheson
P304page(s)S89-97
P577publication date2006-12-01
P1433published inEndocrine-Related CancerQ3054004
P1476titleInductive mechanisms limiting response to anti-epidermal growth factor receptor therapy
P478volume13 Suppl 1

Reverse relations

cites work (P2860)
Q54610139Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
Q28241154Artemin is oncogenic for human mammary carcinoma cells
Q36678664Evaluation of the current knowledge limitations in breast cancer research: a gap analysis
Q36814491Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.
Q37772399Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.
Q39974866Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer
Q34564120Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma

Search more.